ZIANNI, ELISA
ZIANNI, ELISA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization
2025 S. Pelucchi, L.D. Dalt, G.D. Cesare, R. Stringhi, L. D'Andrea, F.L. Greca, C. Cambria, L. Vandermeulen, E. Zianni, S. Musardo, S. Roda, F. Bonacina, S. Nasini, M.G. Lupo, N. Ferri, S. Comai, F. Gardoni, F. Antonucci, D. Scheggia, M.D. Luca, G.D. Norata, E. Marcello
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features
2024 M. Italia, M. Salvadè, F. La Greca, E. Zianni, S. Pelucchi, A. Spinola, E. Ferrari, S. Archetti, A. Alberici, A. Benussi, E. Solje, A. Haapasalo, D. Hoffmann, K. Katisko, J. Krüger, R. Facchinetti, C. Scuderi, A. Padovani, M. Diluca, D. Scheggia, B. Borroni, F. Gardoni
Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses
2023 E. Ferrari, M. Salvadè, E. Zianni, M. Brumana, M. Diluca, F. Gardoni
Antidepressant-induced increase in GluA2 expression does not translate in changes of AMPA receptor-mediated synaptic transmission at CA3/CA1 synapses in rats
2023 E. Gerace, L. Polenzani, M. Magnani, E. Zianni, G. Stocca, F. Gardoni, D.E. Pellegrini-Giampietro, R. Corradetti
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease
2022 E. Ferrari, D. Scheggia, E. Zianni, M. Italia, M. Brumana, L. Palazzolo, C. Parravicini, A. Pilotto, A. Padovani, E. Marcello, I. Eberini, P. Calabresi, M. Diluca, F. Gardoni
Rabphilin-3A Drives Structural Modifications of Dendritic Spines Induced by Long-Term Potentiation
2022 L. Franchini, J. Stanic, M. Barzasi, E. Zianni, D. Mauceri, M. Diluca, F. Gardoni
Reciprocal cortico-amygdala connections regulate prosocial and selfish choices in mice
2022 D. Scheggia, F. LA GRECA, F. Maltese, G. Chiacchierini, M. Italia, C. Molent, F. Bernardi, M.G. Coccia, N. Carrano, E. Zianni, F. Gardoni, M.M.G. Diluca, F. Papaleo
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice
2021 D. Scheggia, J. Stanic, M. Italia, F. La Greca, E. Zianni, A. Benussi, B. Borroni, M. Di Luca, F. Gardoni
Sex-dependent effects of developmental lead exposure in Wistar rats: Evidence from behavioral and molecular correlates
2020 A.M. Tartaglione, M.M. Serafini, A. Raggi, F. Iacoponi, E. Zianni, A. Scalfari, L. Minghetti, L. Ricceri, F. Cubadda, G. Calamandrei, B. Viviani
Differential mechanisms of tolerance induced by NMDA and 3,5-dihydroxyphenylglycine (DHPG) preconditioning
2020 E. Gerace, E. Zianni, E. Landucci, T. Scartabelli, R. Berlinguer Palmini, D. Iezzi, F. Moroni, M. Di Luca, G. Mannaioni, F. Gardoni, D.E. Pellegrini-Giampietro
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.
2020 F. Palese, E. Bonomi, T. Nuzzo, A. Benussi, M. Mellone, E. Zianni, F. Cisani, A. Casamassa, A. Alberici, D. Scheggia, A. Padovani, E. Marcello, M. Di Luca, A. Pittaluga, A. Usiello, B. Borroni, F. Gardoni
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology
2019 M. Mellone, E. Zianni, J. Stanic, F. Campanelli, G. Marino, V. Ghiglieri, A. Longhi, M.L. Thiolat, Q. Li, P. Calabresi, E. Bezard, B. Picconi, M. Di Luca, F. Gardoni
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition
2019 L. Franchini, J. Stanic, L. Ponzoni, M. Mellone, N. Carrano, S. Musardo, E. Zianni, G. Olivero, E. Marcello, A. Pittaluga, M. Sala, C. Bellone, C. Racca, M. Di Luca, F. Gardoni
Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target
2018 B. Borroni, J. Stanic, C. Verpelli, M. Mellone, E. Bonomi, A. Alberici, P. Bernasconi, L. Culotta, E. Zianni, S. Archetti, M. Manes, S. Gazzina, R. Ghidoni, L. Benussi, C. Stuani, M. Di Luca, C. Sala, E. Buratti, A. Padovani, F. Gardoni
Rabphilin 3A : a novel target for the treatment of levodopa-induced dyskinesias
2017 J. Stanic, M. Mellone, F. Napolitano, C. Racca, E. Zianni, D. Minocci, V. Ghiglieri, M. Thiolat, Q. Li, A. Longhi, A. De Rosa, B. Picconi, E. Bezard, P. Calabresi, M. Di Luca, A. Usiello, F. Gardoni
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target
2017 B. Borroni, J. Stanic, C. Verpelli, M. Mellone, E. Bonomi, A. Alberici, P. Bernasconi, L. Culotta, E. Zianni, S. Archetti, M. Manes, S. Gazzina, R. Ghidoni, L. Benussi, C. Stuani, M. Di Luca, C. Sala, E. Buratti, A. Padovani, F. Gardoni
LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias
2016 J. Stanic, M. Mellone, M.D. Cirnaru, M. Perez-Carrion, E. Zianni, M.M.G. Di Luca, F. Gardoni, G. Piccoli
NMDA receptor gluN2A/gluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias : from experimental models to patients
2015 M. Mellone, J. Stanic, L.F. Hernandez, E. Iglesias, E. Zianni, A. Longhi, A. Prigent, B. Picconi, P. Calabresi, E.C. Hirsch, J.A. Obeso, M. Di Luca, F. Gardoni
d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain
2015 L. Cristino, L. Luongo, M. Squillace, G. Paolone, D. Mango, S. Piccinin, E. Zianni, R. Imperatore, M. Iannotta, F. Longo, F. Errico, A.L. Vescovi, M. Morari, S. Maione, F. Gardoni, R. Nisticò, A. Usiello
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
2014 E. Tronci, C. Fidalgo, E. Zianni, M. Collu, R. Stancampiano, M. Morelli, F. Gardoni, M. Carta